[HTML][HTML] Defining the role of the MHC in autoimmunity: a review and pooled analysis

MMA Fernando, CR Stevens, EC Walsh… - PLoS …, 2008 - journals.plos.org
MMA Fernando, CR Stevens, EC Walsh, PL De Jager, P Goyette, RM Plenge, TJ Vyse…
PLoS genetics, 2008journals.plos.org
The major histocompatibility complex (MHC) is one of the most extensively studied regions
in the human genome because of the association of variants at this locus with autoimmune,
infectious, and inflammatory diseases. However, identification of causal variants within the
MHC for the majority of these diseases has remained difficult due to the great variability and
extensive linkage disequilibrium (LD) that exists among alleles throughout this locus,
coupled with inadequate study design whereby only a limited subset of about 20 from a total …
The major histocompatibility complex (MHC) is one of the most extensively studied regions in the human genome because of the association of variants at this locus with autoimmune, infectious, and inflammatory diseases. However, identification of causal variants within the MHC for the majority of these diseases has remained difficult due to the great variability and extensive linkage disequilibrium (LD) that exists among alleles throughout this locus, coupled with inadequate study design whereby only a limited subset of about 20 from a total of approximately 250 genes have been studied in small cohorts of predominantly European origin. We have performed a review and pooled analysis of the past 30 years of research on the role of the MHC in six genetically complex disease traits – multiple sclerosis (MS), type 1 diabetes (T1D), systemic lupus erythematosus (SLE), ulcerative colitis (UC), Crohn's disease (CD), and rheumatoid arthritis (RA) – in order to consolidate and evaluate the current literature regarding MHC genetics in these common autoimmune and inflammatory diseases. We corroborate established MHC disease associations and identify predisposing variants that previously have not been appreciated. Furthermore, we find a number of interesting commonalities and differences across diseases that implicate both general and disease-specific pathogenetic mechanisms in autoimmunity.
PLOS